AquaBounty Technologies' third-quarter report arrives at a pivotal moment for the land-based aquaculture company. After selling its Indiana Farm in July 2024 and its Canadian Farms in March 2025, the company ceased active fish-rearing operations, leaving the Ohio Farm Project as its principal remaining asset. With essentially no revenue, the earnings release matters less for sales figures and more for what it reveals about cash preservation, expense management, and the trajectory of the strategic review. In my view, the report serves as a barometer of whether management can extend its cash runway long enough to complete a transaction for the Ohio site or secure alternative financing while preserving its Nasdaq listing.
Analyst coverage of AQB remains thin, so consensus figures should be interpreted with caution. A limited consensus points to a loss of roughly $1.30 per share on revenue near $0.27 million for the third quarter, though estimates for a company with no active operations carry limited informational value. For context, the company reported a loss of $0.26 per share in both the first and second quarters of 2026, and a loss of $0.36 per share in the third quarter of 2025. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Because revenue is not a meaningful driver at this stage, investors should focus instead on general and administrative expense trends, which fell roughly 33% year over year in the second quarter of 2026, the cash balance, and any update to the going-concern disclosure. Historically, the stock has been more responsive to strategic and financing developments than to headline per-share figures.
Sentiment heading into the third-quarter report remains cautious, reflecting the company's limited cash, ongoing losses, and strategic uncertainty. AquaBounty has raised capital through common stock, warrants, and preferred stock during 2026, including the exchange of senior notes for convertible preferred shares, which has helped push stockholders' equity back into positive territory but also introduced potential dilution for common shareholders. Key risk factors ahead of the release include whether the company can maintain compliance with Nasdaq listing standards, including the Market Value of Listed Securities (MVLS) requirement and minimum bid price rules, and whether the strategic review of the Ohio site yields a definitive transaction. Investors will be listening closely for any commentary on capital raises or asset-sale progress.
The most important item to watch after the earnings release is any concrete progress on the Ohio Farm Project. Management has broadened its review beyond aquaculture to include power generation, energy development, and digital infrastructure, with discussions reportedly ongoing with developers and utilities. A signed sale, lease, or joint-venture agreement would mark a meaningful shift in the company's trajectory.
Liquidity remains the second critical factor. With roughly $1.89 million in cash as of June 30, 2026, the company continues to rely on capital raises and asset sales to fund operations, and management has already raised substantial doubt about its ability to continue as a going concern. Investors should track the cash burn rate and any new financing activity disclosed in the report.
Finally, Nasdaq compliance and capital structure deserve attention. The recent issuance of Series A and Series B convertible preferred stock carries cumulative dividends and conversion rights that could dilute common stockholders over time. Monitoring the stock's price and market capitalization, alongside any updates on listing compliance and preferred-stock terms, will help investors gauge both near-term risk and the potential for a strategic resolution.
I often turn to Tickeron’s AI Screener when preparing for reports like this one. It lets me quickly scan for patterns and signals across similar event-driven names, which helps put the upcoming release in broader context without spending hours on manual review. The tool has become a regular part of how I cross-check ideas before earnings season.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AQB saw its Momentum Indicator move below the 0 level on November 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned negative. In 92 of the 96 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for AQB turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 32 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
AQB moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AQB crossed bearishly below the 50-day moving average on November 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AQB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
AQB broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 73 cases where AQB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
Following a +16.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where AQB advanced for three days, in 160 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 48 of 85 cases where AQB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.793) is normal, around the industry mean (2.266). P/E Ratio (-0.214) is within average values for comparable stocks, (4.366). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.441). AQB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.037). P/S Ratio (2.089) is also within normal values, averaging (2.353).
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. AQB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AQB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a biotechnology company focused on improving productivity in commercial aquaculture
Industry AgriculturalCommoditiesMilling